GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,440 | -4,030 | -2,970 | -1,190 | -7,120 |
| Depreciation Amortization | 830 | 700 | 550 | 280 | 1,550 |
| Other Working Capital | 360 | 120 | 9 | -600 | -250 |
| Other Operating Activity | 780 | 710 | 691 | -10 | 580 |
| Operating Cash Flow | $-2,470 | $-2,500 | $-1,720 | $-1,520 | $-5,240 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,710 | 1,760 | 1,810 | 1,930 | -100 |
| Other Investing Activity | 440 | -50 | -60 | -30 | -140 |
| Investing Cash Flow | $2,150 | $1,710 | $1,750 | $1,900 | $-240 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,470 | -1,550 | -1,510 | -1,500 | 6,830 |
| Financing Cash Flow | $-1,470 | $-1,550 | $-1,510 | $-1,500 | $6,830 |
| Exchange Rate Effect | 20 | 20 | 10 | 20 | -60 |
| Beginning Cash Position | 2,570 | 2,570 | 2,570 | 2,570 | 1,290 |
| End Cash Position | 780 | 240 | 1,100 | 1,480 | 2,570 |
| Net Cash Flow | $-1,780 | $-2,330 | $-1,460 | $-1,090 | $1,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -2,500 | -1,720 | -1,520 | -5,240 |
| Free Cash Flow | -2,470 | -2,500 | -1,720 | -1,520 | -5,240 |